(S)-3-({1-[(S)-2-((3S,4S)-2-Acetylamino-3-methyl-pentanoylamino)-acetyl]-2,3-dihydro-1H-indole-2-carbonyl}-amino)-4-oxo-butyric acid

ID: ALA305293

PubChem CID: 44309905

Max Phase: Preclinical

Molecular Formula: C23H30N4O7

Molecular Weight: 474.51

Molecule Type: Protein

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(C)=O)C(=O)NCC(=O)N1c2ccccc2C[C@H]1C(=O)N[C@H](C=O)CC(=O)O

Standard InChI:  InChI=1S/C23H30N4O7/c1-4-13(2)21(25-14(3)29)23(34)24-11-19(30)27-17-8-6-5-7-15(17)9-18(27)22(33)26-16(12-28)10-20(31)32/h5-8,12-13,16,18,21H,4,9-11H2,1-3H3,(H,24,34)(H,25,29)(H,26,33)(H,31,32)/t13-,16-,18-,21-/m0/s1

Standard InChI Key:  PQDSZTPUEFNPLL-CZBBOPSRSA-N

Molfile:  

     RDKit          2D

 34 35  0  0  1  0  0  0  0  0999 V2000
    5.9042   -2.9750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6750   -3.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8875   -4.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9500   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2125   -3.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1917   -2.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7500   -1.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0375   -3.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4417   -3.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6875   -4.2750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7000   -3.4375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7875   -3.4875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4042   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1250   -2.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1125   -3.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4750   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3000   -4.6500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4000   -3.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2500   -4.2417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8792   -2.3917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8292   -3.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2667   -4.7667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8250   -3.8750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6000   -4.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1042   -4.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1250   -1.8125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3667   -1.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9625   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3625   -3.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0042   -5.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3500   -4.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5792   -0.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3875   -0.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1667   -5.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  1
  4  1  1  0
  5  1  1  0
  6  2  1  0
  7  4  2  0
  8 12  1  0
  9  8  1  0
 10  3  1  0
  9 11  1  6
 12 16  1  0
 18 13  1  1
 14 13  1  0
 15 11  1  0
 16  5  1  0
 17  3  2  0
 18 10  1  0
 19  5  2  0
 20  8  2  0
 21 14  2  0
 22 15  2  0
 23 25  2  0
 24  9  1  0
 25 18  1  0
 26 14  1  0
 27  4  1  0
 28  7  1  0
 29 15  1  0
 30 24  1  0
 24 31  1  1
 32 27  2  0
 33 32  1  0
 34 30  1  0
  7  6  1  0
 28 33  2  0
M  END

Associated Targets(Human)

GZMB Tchem Granzyme B (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 474.51Molecular Weight (Monoisotopic): 474.2114AlogP: -0.23#Rotatable Bonds: 11
Polar Surface Area: 161.98Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.86CX Basic pKa: CX LogP: -0.84CX LogD: -4.08
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: -0.28

References

1. Willoughby CA, Bull HG, Garcia-Calvo M, Jiang J, Chapman KT, Thornberry NA..  (2002)  Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis.,  12  (16): [PMID:12127536] [10.1016/s0960-894x(02)00363-3]

Source